Bionano Genomics (BNGO) Change in Acquisitions & Divestments (2021 - 2026)

Bionano Genomics (BNGO) has 6 years of Change in Acquisitions & Divestments data on file, last reported at $54.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 6.76% year-over-year to $54.1 million; the trailing twelve-month figure through Mar 2026 stood at $232.6 million (up 16.57% YoY), and the FY2025 full-year result was $229.1 million, down 25.36% from the prior year.
• Change in Acquisitions & Divestments retreated to $54.1 million in Q1 2026, from $68.4 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $158.2 million in Q1 2024 to a low of $16.9 million in Q1 2023.
• A 5-year average of $54.6 million and a median of $52.2 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments jumped 836.58% in 2024 and tumbled 67.95% in 2025, its largest moves.
• Tracing BNGO's Change in Acquisitions & Divestments over 5 years: stood at $65.5 million in 2022, then declined by 20.38% to $52.2 million in 2023, then plunged by 58.4% to $21.7 million in 2024, then jumped by 215.1% to $68.4 million in 2025, then declined by 20.82% to $54.1 million in 2026.
• Business Quant data shows BNGO's Change in Acquisitions & Divestments at $54.1 million in Q1 2026, $68.4 million in Q4 2025, and $56.2 million in Q3 2025.